GSK CEO: Big pharma should keep investing in R&D

The alternative acquisition model in the health care industry has drawn criticism during this election year. In theory, the MA strategy can save companies significant sums as they can purchase mature, fully developed products without having to invest in RD. “We’ve turned our face away from some of the more […]

JPMorgan strategist: We see value in these sectors

While the tech sector delivered a mixed bag of earnings results, Rees said he believes areas such as cloud computing, mobility and big data remain intact. JPMorgan intends to add stocks selectively, he said. Health care also looks attractive, he said, despite concerns about pricing during a presidential campaign season […]